Dr. Tammy Z. Movsas, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 220 West Ellsworth St, Midland County Dept Of Public Health, Midland, MI 48640 Phone: 989-832-6380 |
Linferd G Linabery Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1715 E Ashman St, Midland, MI 48642 Phone: 989-631-9140 Fax: 989-631-7227 |
Dr. Carol Lynn Cooper, M.D., PH.D., Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3300 Applewood Rd, Midland, MI 48640 Phone: 989-832-0042 Fax: 989-832-0042 |
Dr. Christopher Jon Bigelow, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 Joseph Dr Ste B, Midland, MI 48642 Phone: 989-631-2020 Fax: 989-835-6686 |
Dr. James Lawrence Jackson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 Joseph Dr Ste B, Midland, MI 48642 Phone: 989-631-2020 Fax: 989-835-6686 |
News Archive
As many as 12 percent of patients undergoing major, non-cardiac surgery experience an irregular heartbeat called atrial fibrillation.
Spencer Hoover, vice president and executive director of the Henry Ford Cancer Institute, is co-author of a manuscript published in the Journal of Oncology Practice aimed at establishing best practices to promote diversity in clinical trials.
Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson's Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).
› Verified 6 days ago